Completely unique to MDS Pharma Services, our Large Molecule Development Program integrates all of the developmental stages for large molecule therapeutics into one efficient process.
The Therapeutic Monoclonal Antibody (mAb) Intellimap illustrates what we can do for you, clearly mapping out all of the phases of mAb development through molecular design, mAb pharmacology, manufacturing process design, product quality control and non-clinical and clinical development. The Intellimap matches our unique solutions to the various questions surrounding development. We want you to feel comfortable knowing that MDS Pharma Services can provide a definitive plan for the development of your large molecule compound.
